Evidence map›Paper›PMID 40177617›Full record

ArticleHemaSphere2025

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.

Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets, Luigi Marcheselli, Caterina Cristinelli, Barbara Botto, Sanne Tonino, Doriane Cavalieri, Alessandro Pulsoni, Martin Hutchings and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gotti ManuelDivision of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Yana StepanishynaDepartment of Hematology Jules Bordet Institute Brussels Belgium.ORCID https://orcid.org/0000-0002-7884-193X
Tetiana SkrypetsHematology and Cell Therapy Unit IRCCS Istituto Tumori "Giovanni Paolo II" Bari Italy.ORCID https://orcid.org/0000-0002-2276-869X
Luigi MarcheselliFIL Trial Office Modena Italy.
Caterina CristinelliHemato-Oncology Department Saint-Louis Hospital Paris France.ORCID https://orcid.org/0000-0002-5757-3569
Barbara BottoDivision of Hematology Ematologia AOU Città della Salute e della Scienza Torino Italy.
Sanne ToninoDepartment of Hematology University Medical Centers Amsterdam, University of Amsterdam Amsterdam The Netherlands.
Doriane CavalieriDepartment of Hematology Lille University Hospital Lille France.
Alessandro PulsoniDipartimento di Medicina Traslazionale e di Precisione Università La Sapienza, Roma and UOC Ematologia e Trapianto Ospedale S. Maria Goretti Latina Italy.
Martin HutchingsDepartment of Hematology Rigshospitalet, University of Copenhagen Copenhagen Denmark.ORCID https://orcid.org/0000-0003-3873-1741
Mohammad HammoudHematology Department Hospital Henri-Mondor AP-HP Creteil France.
Catherine FortpiedStatistics Department EORTC Headquarters Brussels Belgium.
Luigi RigacciFIL Hematology, Campus Bio-Medico University Rome Italy.
Wouter PlattelEORTC University Medical Center Groningen Groningen The Netherlands.ORCID https://orcid.org/0000-0001-9828-9460
Marc AndréDepartment of Hematology CHU UCL Namur Yvoir Belgium.ORCID https://orcid.org/0000-0001-7101-810X
Massimo FedericoCHIMOMO Department University of Modena and Reggio Emilia Modena Italy.ORCID https://orcid.org/0000-0002-9889-3796

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40177617
PMCPMC11962756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.